1	Chinese	chinese	JJ	_	3	amod	_
2	corruption	corruption	NN	_	3	nn	_
3	charges	charge	NNS	p2=VBZ	15	nsubj	15:A1=PPT
4	against	against	IN	_	3	prep	_
5	executives	executive	NNS	_	4	pobj	_
6	of	of	IN	_	5	prep	_
7	British	british	JJ	p2=NNP	8	amod	_
8	drugmaker	drugmaker	NN	p2=JJR	10	nn	_
9	GlaxoSmithKline	glaxosmithkline	NNP	_	10	nn	_
10	Plc	plc	NNP	_	6	pobj	_
11	(	(	-LRB-	_	10	punct	_
12	GSK	gsk	NNP	_	10	appos	_
13	)	)	-RRB-	_	10	punct	_
14	could	could	MD	_	15	aux	15:AM-MOD
15	be	be	VB	pb=be.01	0	root	_
16	just	just	RB	_	18	advmod	_
17	the	the	DT	_	18	det	_
18	start	start	NN	_	15	attr	15:A2=PRD
19	of	of	IN	_	18	prep	_
20	the	the	DT	_	22	det	_
21	pharmaceutical	pharmaceutical	JJ	_	22	amod	_
22	industry	industry	NN	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	problems	problem	NNS	_	19	pobj	_
25	in	in	IN	_	24	prep	_
26	its	its	PRP$	_	30	poss	_
27	biggest	big	JJS	_	30	amod	_
28	emerging	emerge	VBG	p2=NN|pb=emerge.01	30	amod	_
29	drugs	drug	NNS	_	30	nn	_
30	market	market	NN	_	25	pobj	28:A0=PPT
31	,	,	,	_	15	punct	_
32	according	accord	VBG	_	15	prep	15:AM-ADV
33	to	to	IN	_	32	prep	_
34	industry	industry	NN	_	35	nn	_
35	sources	source	NNS	_	33	pobj	_
36	in	in	IN	_	35	prep	_
37	China	china	NNP	_	36	pobj	_
38	.	.	.	_	15	punct	_

1	The	the	DT	_	2	det	_
2	charges	charge	NNS	_	28	nsubjpass	3:A1=PPT;28:A1=PPT
3	relating	relate	VBG	pb=relate.01	2	partmod	_
4	to	to	IN	_	3	prep	3:A2=PPT
5	GSK	gsk	NNP	_	6	nn	_
6	executives	executive	NNS	_	4	pobj	10:A0=PAG;8:A1=PPT
7	,	,	,	_	6	punct	_
8	accused	accuse	VBN	pb=accuse.01	6	partmod	_
9	of	of	IN	_	8	prep	8:A2=PRD
10	funnelling	funnel	VBG	p2=JJ|pb=funnel.01	9	pcomp	_
11	hundreds	#crd#	NNS	_	13	quantmod	_
12	of	of	IN	_	13	quantmod	_
13	millions	#crd#	NNS	_	10	dobj	10:A1=PPT
14	of	of	IN	_	13	prep	_
15	dollars	dollar	NNS	_	14	pobj	_
16	in	in	IN	_	10	prep	_
17	bribes	bribe	NNS	_	16	pobj	_
18	to	to	IN	_	10	prep	10:A2=GOL
19	doctors	doctor	NNS	_	18	pobj	_
20	and	and	CC	_	19	cc	_
21	health	health	NN	_	22	nn	_
22	officials	official	NNS	_	19	conj	_
23	via	via	IN	_	10	prep	_
24	travel	travel	NN	_	25	nn	_
25	agencies	agency	NNS	_	23	pobj	_
26	,	,	,	_	6	punct	_
27	were	be	VBD	_	28	auxpass	_
28	announced	announce	VBN	pb=announce.01	0	root	_
29	by	by	IN	_	28	agent	28:A0=PAG
30	Chinese	chinese	JJ	_	31	amod	_
31	authorities	authority	NNS	_	29	pobj	_
32	last	last	JJ	_	33	amod	_
33	week	week	NN	_	28	npadvmod	28:AM-TMP
34	,	,	,	_	28	punct	_
35	the	the	DT	_	36	det	_
36	culmination	culmination	NN	_	28	npadvmod	_
37	of	of	IN	_	36	prep	_
38	a	a	DT	_	43	det	_
39	10	0	CD	_	41	hmod	_
40	-	-	HYPH	_	41	hyph	_
41	month	month	NN	_	43	nn	_
42	police	police	NN	_	43	nn	_
43	investigation	investigation	NN	_	37	pobj	_
44	.	.	.	_	28	punct	_

1	But	but	CC	_	5	cc	5:AM-DIS
2	the	the	DT	_	4	det	_
3	GSK	gsk	NNP	_	4	nn	_
4	case	case	NN	_	5	nsubj	8:A0=PAG;5:A1=PPT
5	is	be	VBZ	pb=be.01	0	root	_
6	unlikely	unlikely	JJ	_	5	acomp	5:A2=PRD
7	to	to	TO	_	8	aux	_
8	represent	represent	VB	pb=represent.01	6	xcomp	_
9	closure	closure	NN	_	8	dobj	8:A1=PPT
10	for	for	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	drugs	drug	NNS	_	13	nn	_
13	industry	industry	NN	_	10	pobj	_
14	in	in	IN	_	13	prep	_
15	China	china	NNP	_	14	pobj	21:A1=PPT;19:A1
16	,	,	,	_	15	punct	_
17	which	which	WDT	_	19	nsubjpass	19:R-A1;21:R-A1
18	is	be	VBZ	_	19	auxpass	_
19	set	set	VBN	pb=set.08	15	rcmod	_
20	to	to	TO	_	21	aux	_
21	become	become	VB	pb=become.01	19	xcomp	19:A2=PRD
22	the	the	DT	_	23	det	_
23	world	world	NN	_	29	poss	_
24	's	's	POS	_	23	possessive	_
25	second	#ord#	RB	_	27	hmod	_
26	-	-	HYPH	_	27	hyph	_
27	biggest	big	JJS	_	29	amod	_
28	pharmaceutical	pharmaceutical	NN	p2=JJ	29	nn	_
29	market	market	NN	_	21	attr	21:A2=PRD
30	behind	behind	IN	_	29	prep	_
31	the	the	DT	_	33	det	_
32	United	united	NNP	_	33	nn	_
33	States	states	NNP	_	30	pobj	_
34	within	within	IN	_	21	prep	21:AM-TMP
35	three	#crd#	CD	_	36	num	_
36	years	year	NNS	_	34	pobj	_
37	according	accord	VBG	_	19	prep	_
38	to	to	IN	_	37	prep	_
39	consultancy	consultancy	NN	p2=NNP	41	nn	_
40	IMS	ims	NNP	p2=IN	41	nn	_
41	Health	health	NNP	_	38	pobj	_
42	.	.	.	_	5	punct	_

1	Drug	drug	NN	p2=JJ	3	hmod	_
2	-	-	HYPH	_	3	hyph	_
3	company	company	NN	_	4	nn	_
4	executives	executive	NNS	_	13	nsubj	13:A0
5	,	,	,	_	4	punct	_
6	sales	sale	NNS	_	7	nn	_
7	staff	staff	NN	p2=VBP	4	appos	_
8	,	,	,	_	7	punct	_
9	lawyers	lawyer	NNS	_	7	conj	_
10	and	and	CC	_	9	cc	_
11	compliance	compliance	NN	_	12	nn	_
12	experts	expert	NNS	_	9	conj	_
13	say	say	VBP	pb=say.01	0	root	_
14	China	china	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	crackdown	crackdown	NN	_	24	nsubj	24:A1=PPT
17	on	on	IN	_	16	prep	_
18	drugmakers	drugmaker	NNS	_	17	pobj	_
19	and	and	CC	_	18	cc	_
20	other	other	JJ	_	22	amod	_
21	healthcare	healthcare	NN	p2=JJ	22	nn	_
22	firms	firm	NNS	_	18	conj	_
23	is	be	VBZ	_	24	aux	_
24	intensifying	intensify	VBG	pb=intensify.01	13	ccomp	13:A1=PPT
25	as	as	IN	_	27	mark	_
26	prosecutors	prosecutor	NNS	_	27	nsubj	27:A1=PPT
27	grow	grow	VBP	p2=VB|pb=grow.02	24	advcl	24:AM-TMP
28	bolder	bold	JJR	p2=NN	27	acomp	27:A2=PRD
29	in	in	IN	_	28	prep	_
30	the	the	DT	_	31	det	_
31	wake	wake	NN	_	29	pobj	_
32	of	of	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	GSK	gsk	NNP	_	35	nn	_
35	case	case	NN	_	32	pobj	_
36	,	,	,	_	24	punct	_
37	threatening	threaten	VBG	pb=threaten.01	24	advcl	_
38	to	to	TO	p2=IN	39	aux	_
39	stymie	stymie	VB	pb=stymie.01	37	xcomp	37:A1=PPT
40	the	the	DT	_	41	det	_
41	growth	growth	NN	_	39	dobj	39:A1=PPT
42	of	of	IN	_	41	prep	_
43	any	any	DT	_	44	det	_
44	firms	firm	NNS	_	42	pobj	45:A1=PPT
45	caught	catch	VBN	pb=catch.03	44	partmod	_
46	in	in	IN	_	45	prep	45:A2
47	the	the	DT	_	48	det	_
48	crosshairs	crosshair	NNS	p2=NN	46	pobj	_
49	of	of	IN	_	48	prep	_
50	the	the	DT	_	53	det	_
51	prolonged	prolonged	JJ	p2=VBN	52	amod	_
52	corruption	corruption	NN	_	53	nn	_
53	crackdown	crackdown	NN	_	49	pobj	_
54	.	.	.	_	13	punct	_

1	"	"	``	_	8	punct	_
2	The	the	DT	_	3	det	_
3	investigation	investigation	NN	_	8	nsubj	8:A1=PPT
4	against	against	IN	_	3	prep	_
5	GSK	gsk	NNP	p2=NN	4	pobj	_
6	may	may	MD	_	8	aux	8:AM-MOD
7	be	be	VB	_	8	aux	_
8	coming	come	VBG	pb=come.04	41	ccomp	41:A1=PPT
9	to	to	IN	_	8	prep	8:A2=PRD
10	a	a	DT	_	11	det	_
11	close	close	JJ	p2=NN	9	pobj	_
12	,	,	,	_	8	punct	_
13	but	but	CC	_	8	cc	_
14	these	these	DT	_	15	det	_
15	types	type	NNS	_	23	nsubj	23:A1=PPT
16	of	of	IN	_	15	prep	_
17	probes	probe	NNS	_	16	pobj	_
18	in	in	IN	_	15	prep	_
19	the	the	DT	_	21	det	_
20	pharmaceutical	pharmaceutical	JJ	p2=NN	21	amod	_
21	sector	sector	NN	_	18	pobj	_
22	are	be	VBP	_	23	aux	_
23	becoming	become	VBG	pb=become.01	8	conj	_
24	a	a	DT	_	26	det	_
25	weekly	weekly	JJ	_	26	amod	_
26	occurrence	occurrence	NN	_	23	dobj	23:A2=PRD
27	,	,	,	_	41	punct	_
28	"	"	''	p2=``	41	punct	_
29	a	a	DT	_	31	det	_
30	sales	sale	NNS	_	31	nn	_
31	rep	rep	NN	_	41	nsubj	41:A0
32	for	for	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	Chinese	chinese	JJ	_	35	amod	_
35	unit	unit	NN	_	32	pobj	_
36	of	of	IN	_	35	prep	_
37	a	a	DT	_	40	det	_
38	major	major	JJ	_	40	amod	_
39	global	global	JJ	_	40	amod	_
40	drugmaker	drugmaker	NN	_	36	pobj	_
41	said	say	VBD	pb=say.01	0	root	_
42	.	.	.	_	41	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG
2	requested	request	VBD	pb=request.01	0	root	_
3	his	his	PRP$	_	4	poss	_
4	name	name	NN	_	11	nsubjpass	11:A1=PPT
5	and	and	CC	_	4	cc	_
6	his	his	PRP$	_	7	poss	_
7	firm	firm	NN	_	9	poss	_
8	's	's	POS	_	7	possessive	_
9	name	name	NN	_	4	conj	_
10	be	be	VB	_	11	auxpass	_
11	withheld	withhold	VBN	pb=withhold.01	2	ccomp	2:A1=PPT
12	due	due	IN	_	11	prep	11:AM-CAU
13	to	to	IN	_	12	pcomp	_
14	the	the	DT	_	15	det	_
15	sensitivity	sensitivity	NN	_	12	pobj	_
16	of	of	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	topic	topic	NN	_	16	pobj	_
19	.	.	.	_	2	punct	_

1	After	after	IN	_	32	prep	32:AM-TMP
2	a	a	DT	_	3	det	_
3	series	series	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	probes	probe	NNS	_	4	pobj	_
6	against	against	IN	_	5	prep	_
7	foreign	foreign	JJ	_	8	amod	_
8	drugmakers	drugmaker	NNS	_	6	pobj	_
9	last	last	JJ	p2=VBP	10	amod	_
10	year	year	NN	_	3	npadvmod	_
11	,	,	,	_	32	punct	_
12	a	a	DT	_	13	det	_
13	range	range	NN	_	32	nsubj	32:A0=PAG
14	of	of	IN	_	13	prep	_
15	government	government	NN	_	16	nn	_
16	bodies	body	NNS	_	14	pobj	_
17	,	,	,	_	13	punct	_
18	including	include	VBG	_	13	prep	_
19	the	the	DT	_	22	det	_
20	state	state	NN	_	22	nn	_
21	planning	planning	NN	p2=VBG	22	nn	_
22	agency	agency	NN	_	18	pobj	_
23	,	,	,	_	22	punct	_
24	local	local	JJ	_	26	amod	_
25	commerce	commerce	NN	_	26	nn	_
26	bureaus	bureaus	NN	_	22	conj	_
27	and	and	CC	_	26	cc	_
28	the	the	DT	_	30	det	_
29	health	health	NN	_	30	nn	_
30	ministry	ministry	NN	_	26	conj	_
31	are	be	VBP	_	32	aux	_
32	making	make	VBG	pb=make.02	49	ccomp	49:A1=PPT
33	frequent	frequent	JJ	_	39	amod	_
34	,	,	,	_	39	punct	_
35	sometimes	sometimes	RB	_	36	advmod	_
36	unannounced	unannounced	JJ	_	39	amod	_
37	spot	spot	NN	_	39	hmod	_
38	-	-	HYPH	p2=,	39	hyph	_
39	checks	check	NNS	_	32	dobj	32:AM-PRR
40	at	at	IN	_	32	prep	32:AM-LOC
41	foreign	foreign	JJ	_	43	amod	_
42	healthcare	healthcare	NN	_	43	nn	_
43	firms	firm	NNS	_	40	pobj	_
44	,	,	,	_	43	punct	_
45	risk	risk	NN	_	46	nn	_
46	consultants	consultant	NNS	_	43	conj	_
47	and	and	CC	_	46	cc	_
48	lawyers	lawyer	NNS	_	46	conj	_
49	said	say	VBD	pb=say.01	0	root	_
50	.	.	.	_	49	punct	_

1	Lawyers	lawyer	NNS	_	2	nsubj	2:A0=PAG
2	estimate	estimate	VBP	pb=estimate.01	0	root	_
3	that	that	IN	p2=RB	15	complm	_
4	more	more	JJR	p2=RBR	6	amod	_
5	than	than	IN	_	6	quantmod	_
6	half	half	NN	p2=PDT	15	nsubjpass	15:A1
7	of	of	IN	_	6	prep	_
8	all	all	DT	_	9	det	_
9	drugmakers	drugmaker	NNS	_	7	pobj	10:A1=PPT
10	operating	operate	VBG	p2=NN|pb=operate.01	9	partmod	_
11	in	in	IN	_	10	prep	10:AM-LOC
12	China	china	NNP	_	11	pobj	_
13	are	be	VBP	_	15	aux	_
14	being	be	VBG	_	15	auxpass	_
15	investigated	investigate	VBN	pb=investigate.01	2	ccomp	2:A1=PPT
16	in	in	IN	_	15	prep	15:AM-MNR
17	some	some	DT	_	18	det	_
18	capacity	capacity	NN	_	16	pobj	_
19	,	,	,	_	1	punct	_
20	from	from	IN	_	15	prep	15:A2=PPT
21	large	large	JJ	_	23	amod	_
22	multinational	multinational	JJ	_	23	amod	_
23	firms	firm	NNS	_	20	pobj	_
24	to	to	IN	_	23	prep	_
25	Chinese	chinese	JJ	_	29	amod	_
26	state	state	NN	_	28	hmod	28:A0=PAG
27	-	-	HYPH	_	28	hyph	_
28	owned	own	VBN	pb=own.01	29	amod	_
29	enterprises	enterprise	NNS	_	24	pobj	28:A1=PPT
30	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	impact	impact	NN	_	7	nsubj	7:A1=PPT
3	of	of	IN	_	2	prep	_
4	an	an	DT	_	5	det	_
5	investigation	investigation	NN	_	3	pobj	_
6	can	can	MD	_	7	aux	7:AM-MOD
7	be	be	VB	pb=be.01	0	root	_
8	significant	significant	JJ	_	7	acomp	7:A2=PRD
9	.	.	.	_	7	punct	_

1	GSK	gsk	NNP	p2=NN	3	poss	_
2	's	's	POS	_	1	possessive	_
3	revenues	revenue	NNS	_	7	nsubj	7:A1=PPT;18:A1=PPT
4	in	in	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	country	country	NN	_	4	pobj	_
7	plunged	plunge	VBD	pb=plunge.01	0	root	_
8	61	0	CD	_	10	num	_
9	per	per	NN	p2=IN	10	nn	_
10	cent	cent	NN	_	7	npadvmod	7:A2=EXT
11	in	in	IN	_	7	prep	7:AM-TMP
12	the	the	DT	_	14	det	_
13	third	#ord#	JJ	_	14	amod	_
14	quarter	quarter	NN	_	11	pobj	_
15	last	last	JJ	_	16	amod	_
16	year	year	NN	_	14	npadvmod	_
17	and	and	CC	_	7	cc	_
18	were	be	VBD	pb=be.01	7	conj	_
19	still	still	RB	_	18	advmod	18:AM-TMP
20	down	down	RB	p2=JJ	18	advmod	18:A2=PRD
21	by	by	IN	_	18	prep	_
22	20	0	CD	_	24	num	_
23	per	per	NN	p2=IN	24	nn	_
24	cent	cent	NN	_	21	pobj	_
25	in	in	IN	_	18	prep	18:AM-TMP
26	the	the	DT	_	28	det	_
27	first	#ord#	JJ	_	28	amod	_
28	quarter	quarter	NN	_	25	pobj	_
29	of	of	IN	_	28	prep	_
30	2014	0	CD	_	29	pobj	_
31	from	from	IN	_	18	prep	_
32	a	a	DT	_	33	det	_
33	year	year	NN	_	34	npadvmod	_
34	earlier	early	RBR	_	31	pcomp	_
35	.	.	.	_	7	punct	_

1	Official	official	JJ	_	3	amod	_
2	Chinese	chinese	JJ	_	3	amod	_
3	media	medium	NNS	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	on	on	IN	_	4	prep	4:AM-TMP
6	Friday	friday	NNP	_	5	pobj	_
7	that	that	IN	_	12	complm	_
8	the	the	DT	_	9	det	_
9	firm	firm	NN	p2=JJ	12	nsubj	12:A0=PPT
10	might	might	MD	_	12	aux	12:AM-MOD
11	have	have	VB	_	12	aux	_
12	suffered	suffer	VBN	pb=suffer.01	4	ccomp	4:A1=PPT
13	"	"	``	_	15	punct	_
14	irreparable	irreparable	JJ	_	15	amod	_
15	damage	damage	NN	_	12	dobj	12:A1=PAG
16	"	"	''	_	15	punct	_
17	in	in	IN	_	12	prep	12:AM-LOC
18	the	the	DT	_	20	det	_
19	Chinese	chinese	JJ	_	20	amod	_
20	market	market	NN	_	17	pobj	_
21	.	.	.	_	4	punct	_

1	Legal	legal	JJ	_	2	amod	_
2	sources	source	NNS	_	13	nsubj	13:A0
3	and	and	CC	_	2	cc	_
4	one	#crd#	CD	_	5	num	_
5	source	source	NN	_	2	conj	_
6	with	with	IN	_	5	prep	_
7	direct	direct	JJ	_	8	amod	_
8	knowledge	knowledge	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	GSK	gsk	NNP	_	12	nn	_
12	investigation	investigation	NN	_	9	pobj	_
13	said	say	VBD	pb=say.01	0	root	_
14	China	china	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	authorities	authority	NNS	_	19	nsubj	19:A0=PAG;21:A0=PAG
17	might	might	MD	_	19	aux	19:AM-MOD
18	still	still	RB	_	19	advmod	19:AM-TMP
19	try	try	VB	pb=try.01	13	ccomp	13:A1=PPT
20	to	to	TO	_	21	aux	_
21	charge	charge	VB	pb=charge.01	19	xcomp	19:A1=PPT
22	the	the	DT	_	23	det	_
23	company	company	NN	_	21	dobj	29:A0=PAG;21:A1=VSP
24	itself	itself	PRP	_	23	appos	_
25	,	,	,	_	23	punct	_
26	which	which	WDT	_	29	nsubj	29:R-A0
27	could	could	MD	_	29	aux	29:AM-MOD
28	potentially	potentially	RB	_	29	advmod	29:AM-ADV
29	put	put	VB	p2=VBD|pb=put.01	23	rcmod	_
30	GSK	gsk	NNP	_	32	poss	_
31	's	's	POS	_	30	possessive	_
32	business	business	NN	_	29	dobj	29:A1=PPT
33	licences	licence	VBZ	p2=NNS|pb=licence.01	29	advcl	_
34	to	to	TO	_	35	aux	_
35	operate	operate	VB	pb=operate.01	33	xcomp	33:A1
36	in	in	IN	_	35	prep	35:AM-LOC
37	China	china	NNP	_	36	pobj	_
38	at	at	IN	_	35	prep	35:AM-MNR
39	risk	risk	NN	_	38	pobj	_
40	.	.	.	_	13	punct	_

1	GSK	gsk	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	in	in	IN	_	2	prep	2:AM-LOC
4	a	a	DT	_	5	det	_
5	statement	statement	NN	_	3	pobj	_
6	on	on	IN	_	5	prep	_
7	Wednesday	wednesday	NNP	_	6	pobj	_
8	that	that	IN	p2=WDT	11	complm	_
9	the	the	DT	_	10	det	_
10	firm	firm	NN	_	11	nsubj	11:A0=PAG;14:A0=PAG
11	wanted	want	VBD	pb=want.01	2	ccomp	2:A1=PPT
12	"	"	``	_	11	punct	_
13	to	to	TO	_	14	aux	_
14	reach	reach	VB	pb=reach.01	11	xcomp	11:A1=PPT
15	a	a	DT	_	16	det	_
16	resolution	resolution	NN	_	14	dobj	19:A0=PAG;14:A1=GOL
17	that	that	WDT	_	19	nsubj	19:R-A0
18	will	will	MD	_	19	aux	19:AM-MOD
19	enable	enable	VB	pb=enable.01	16	rcmod	_
20	the	the	DT	_	21	det	_
21	company	company	NN	_	19	dobj	23:A0=PAG;25:A0=PAG;19:A2
22	to	to	TO	_	23	aux	_
23	continue	continue	VB	pb=continue.01	19	xcomp	19:A1=PPT
24	to	to	TO	_	25	aux	_
25	make	make	VB	pb=make.02	23	xcomp	23:A1=PPT
26	an	an	DT	_	28	det	_
27	important	important	JJ	_	28	amod	_
28	contribution	contribution	NN	_	25	dobj	25:AM-PRR
29	to	to	IN	_	28	prep	_
30	the	the	DT	_	31	det	_
31	health	health	NN	_	29	pobj	_
32	and	and	CC	_	31	cc	_
33	welfare	welfare	NN	_	31	conj	_
34	of	of	IN	_	31	prep	_
35	China	china	NNP	_	34	pobj	_
36	and	and	CC	_	35	cc	_
37	its	its	PRP$	_	38	poss	_
38	citizens	citizen	NNS	_	35	conj	_
39	"	"	''	_	38	punct	_
40	.	.	.	_	2	punct	_

1	A	a	DT	_	5	det	_
2	London	london	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	based	base	VBN	_	5	amod	_
5	spokesman	spokesman	NN	_	6	nsubj	6:A0=PAG;8:A0=PAG
6	declined	decline	VBD	pb=decline.02	0	root	_
7	to	to	TO	_	8	aux	_
8	elaborate	elaborate	VB	pb=elaborate.01	6	xcomp	6:A1=PPT
9	on	on	IN	p2=RP	8	prep	8:A1=PPT
10	Friday	friday	NNP	_	9	pobj	_
11	.	.	.	_	6	punct	_

1	Chinese	chinese	JJ	_	2	amod	_
2	authorities	authority	NNS	_	28	nsubj	28:A0=PAG;4:A1=PPT
3	,	,	,	_	28	punct	_
4	led	lead	VBN	pb=lead.02	28	advcl	28:AM-PRD
5	by	by	IN	_	4	agent	4:A0=PAG
6	the	the	DT	_	8	det	_
7	State	state	NNP	_	8	nn	_
8	Administration	administration	NNP	_	5	pobj	_
9	for	for	IN	_	8	prep	_
10	Industry	industry	NNP	p2=NN	9	pobj	_
11	and	and	CC	_	10	cc	_
12	Commerce	commerce	NNP	_	10	conj	_
13	(	(	-LRB-	_	14	punct	_
14	SAIC	saic	NNP	_	8	appos	_
15	)	)	-RRB-	_	14	punct	_
16	and	and	CC	_	8	cc	_
17	the	the	DT	_	18	det	_
18	country	country	NN	_	22	poss	_
19	's	's	POS	_	18	possessive	_
20	public	public	JJ	_	21	amod	_
21	security	security	NN	_	22	nn	_
22	bureau	bureau	NN	_	8	conj	_
23	(	(	-LRB-	_	24	punct	_
24	PSB	psb	NNP	_	22	appos	_
25	)	)	-RRB-	_	24	punct	_
26	,	,	,	_	28	punct	_
27	are	be	VBP	_	28	aux	_
28	ramping	ramp	VBG	pb=ramp.01	0	root	_
29	up	up	RP	p2=IN	28	prt	28:C-V
30	their	their	PRP$	_	31	poss	_
31	visits	visit	NNS	_	28	dobj	28:A1=PPT
32	to	to	IN	_	31	prep	_
33	foreign	foreign	JJ	_	35	amod	_
34	drug	drug	NN	_	35	nn	_
35	firms	firm	NNS	_	32	pobj	_
36	.	.	.	_	28	punct	_

1	"	"	``	_	6	punct	_
2	We	we	PRP	_	6	nsubjpass	_
3	have	have	VBP	_	6	aux	_
4	certainly	certainly	RB	_	6	advmod	6:AM-ADV
5	been	be	VBN	_	6	auxpass	_
6	made	make	VBN	pb=make.02	28	ccomp	28:A1=PPT
7	aware	aware	JJ	_	6	oprd	6:A1=PRD
8	from	from	IN	_	7	prep	_
9	clients	client	NNS	_	8	pobj	_
10	that	that	IN	p2=WDT	18	complm	_
11	inspection	inspection	NN	_	12	nn	_
12	visits	visit	NNS	_	18	nsubj	18:A1=PPT
13	by	by	IN	_	12	prep	_
14	various	various	JJ	_	16	amod	_
15	government	government	NN	_	16	nn	_
16	agencies	agency	NNS	_	13	pobj	_
17	have	have	VBP	_	18	aux	_
18	increased	increase	VBN	pb=increase.01	9	rcmod	_
19	and	and	CC	_	18	cc	_
20	these	these	DT	_	21	det	_
21	visits	visit	NNS	_	22	nsubj	22:A1=PPT
22	are	be	VBP	pb=be.01	18	conj	_
23	now	now	RB	_	22	advmod	22:AM-TMP
24	more	more	RBR	p2=JJR	25	advmod	_
25	focused	focused	JJ	p2=VBN	22	acomp	22:A2=PRD
26	,	,	,	_	28	punct	_
27	"	"	''	_	28	punct	_
28	said	say	VBD	pb=say.01	0	root	_
29	risk	risk	NN	_	30	nn	_
30	consultant	consultant	NN	_	32	nn	_
31	Bob	bob	NNP	_	32	nn	_
32	Youill	youill	NNP	_	28	nsubj	28:A0
33	,	,	,	_	32	punct	_
34	Shanghai	shanghai	NNP	_	36	hmod	_
35	-	-	HYPH	_	36	hyph	_
36	based	base	VBN	_	38	amod	_
37	managing	managing	NN	p2=VBG	38	amod	_
38	director	director	NN	_	32	appos	_
39	at	at	IN	_	38	prep	_
40	FTI	fti	NNP	_	41	nn	_
41	Consulting	consulting	NNP	_	39	pobj	_
42	.	.	.	_	28	punct	_

1	Authorities	authority	NNS	_	3	nsubj	3:A0=PPT
2	are	be	VBP	_	3	aux	_
3	looking	look	VBG	pb=look.01	0	root	_
4	to	to	TO	p2=IN	3	prep	3:A1=GOL
5	unearth	unearth	JJ	p2=VB	6	amod	_
6	proof	proof	NN	_	4	pobj	_
7	that	that	IN	p2=WDT	10	complm	_
8	firms	firm	NNS	_	10	nsubj	10:A0=PAG
9	have	have	VBP	_	10	aux	_
10	violated	violate	VBN	pb=violate.01	6	ccomp	_
11	anti-corruption	anti-corruption	JJ	p2=NN	12	amod	_
12	laws	law	NNS	_	10	dobj	10:A1=PPT
13	or	or	CC	_	12	cc	_
14	artificially	artificially	RB	_	15	advmod	_
15	inflated	inflated	JJ	p2=VBN	17	amod	_
16	drug	drug	NN	_	17	nn	_
17	prices	price	NNS	_	12	conj	_
18	,	,	,	_	17	punct	_
19	a	a	DT	_	21	det	_
20	sensitive	sensitive	JJ	_	21	amod	_
21	theme	theme	NN	_	1	appos	_
22	as	as	IN	_	26	mark	_
23	China	china	NNP	_	25	poss	_
24	's	's	POS	_	23	possessive	_
25	leaders	leader	NNS	_	26	nsubj	26:A0=PAG;28:A0=PAG
26	look	look	VBP	pb=look.04	21	advcl	_
27	to	to	TO	_	28	aux	_
28	provide	provide	VB	pb=provide.01	26	xcomp	26:A1=PPT
29	affordable	affordable	JJ	_	30	amod	_
30	healthcare	healthcare	NN	_	28	dobj	28:A1=PPT
31	to	to	IN	_	28	prep	28:A2=GOL
32	the	the	DT	_	33	det	_
33	country	country	NN	_	39	poss	_
34	's	's	POS	_	33	possessive	_
35	near	near	JJ	p2=RB	37	hmod	_
36	-	-	HYPH	p2=SYM	37	hyph	_
37	1.4	0	CD	_	38	number	_
38	billion	#crd#	CD	_	39	num	_
39	people	people	NNS	_	31	pobj	_
40	.	.	.	_	3	punct	_

1	Last	last	JJ	_	3	amod	_
2	year	year	NN	_	3	nn	_
3	authorities	authority	NNS	_	4	nsubj	4:A0=PAG
4	visited	visit	VBD	pb=visit.01	0	root	_
5	large	large	JJ	_	8	amod	_
6	international	international	JJ	_	8	amod	_
7	drugs	drug	NNS	_	8	nn	_
8	manufacturers	manufacturer	NNS	_	4	dobj	4:A1=COM
9	including	include	VBG	_	8	prep	_
10	Novartis	novartis	NNP	_	11	nn	_
11	AG	ag	NNP	_	9	pobj	_
12	,	,	,	_	11	punct	_
13	AstraZeneca	astrazeneca	NNP	_	14	nn	_
14	Plc	plc	NNP	_	11	conj	_
15	,	,	,	_	14	punct	_
16	Sanofi	sanofi	NNP	_	17	nn	_
17	SA	sa	NNP	_	14	conj	_
18	,	,	,	_	17	punct	_
19	Eli	eli	NNP	_	20	nn	_
20	Lilly	lilly	NNP	_	17	conj	_
21	&	&	CC	_	20	cc	_
22	Co	co	NNP	_	20	conj	_
23	and	and	CC	_	20	cc	_
24	Bayer	bayer	NNP	_	25	nn	_
25	AG	ag	NNP	_	20	conj	_
26	as	as	IN	_	4	prep	4:AM-ADV
27	part	part	NN	_	26	pobj	_
28	of	of	IN	_	27	prep	_
29	a	a	DT	_	31	det	_
30	broad	broad	JJ	_	31	amod	_
31	investigation	investigation	NN	_	28	pobj	_
32	into	into	IN	_	31	prep	_
33	the	the	DT	_	34	det	_
34	sector	sector	NN	_	32	pobj	_
35	.	.	.	_	4	punct	_

1	Bayer	bayer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	its	its	PRP$	_	4	poss	_
4	contacts	contact	NNS	_	7	nsubj	7:A1=PPT
5	with	with	IN	_	4	prep	_
6	regulators	regulator	NNS	_	5	pobj	_
7	were	be	VBD	pb=be.01	2	ccomp	2:A1=PPT
8	within	within	IN	_	7	prep	7:A2=PRD
9	the	the	DT	_	11	det	_
10	normal	normal	JJ	_	11	amod	_
11	range	range	NN	_	8	pobj	_
12	.	.	.	_	2	punct	_

1	Johnson	johnson	NNP	_	4	nn	_
2	&	&	CC	_	1	cc	_
3	Johnson	johnson	NNP	_	1	conj	_
4	spokesman	spokesman	NN	_	6	nn	_
5	Ernie	ernie	NNP	_	6	nn	_
6	Knewitz	knewitz	NNP	_	7	nsubj	7:A0
7	said	say	VBD	pb=say.01	0	root	_
8	he	he	PRP	_	9	nsubj	9:A1=PPT
9	was	be	VBD	pb=be.01	7	ccomp	7:A1=PPT
10	unaware	unaware	JJ	_	9	acomp	9:A2=PRD
11	of	of	IN	_	10	prep	_
12	any	any	DT	_	15	det	_
13	"	"	``	_	15	punct	_
14	new	new	JJ	_	15	amod	_
15	developments	development	NNS	_	11	pobj	_
16	"	"	''	_	15	punct	_
17	in	in	IN	_	15	prep	_
18	China	china	NNP	_	17	pobj	_
19	.	.	.	_	7	punct	_

1	Chinese	chinese	JJ	_	2	amod	_
2	subsidiaries	subsidiary	NNS	_	12	nsubj	12:A0=PAG;17:A0=PAG
3	of	of	IN	_	2	prep	_
4	US	us	NNP	_	5	nn	_
5	drugmaker	drugmaker	NN	p2=NNP	6	nn	_
6	Merck	merck	NNP	_	3	pobj	_
7	&	&	CC	_	6	cc	_
8	Co	co	NNP	_	9	nn	_
9	Inc	inc	NNP	_	6	conj	_
10	"	"	''	p2=NNPS	9	punct	_
11	have	have	VBP	_	12	aux	_
12	received	receive	VBN	pb=receive.01	33	ccomp	33:A1=PPT
13	and	and	CC	_	12	cc	_
14	may	may	MD	_	15	aux	15:AM-MOD
15	continue	continue	VB	pb=continue.01	12	conj	_
16	to	to	TO	_	17	aux	_
17	receive	receive	VB	pb=receive.01	15	xcomp	15:A1=PPT
18	inquiries	inquiry	NNS	_	17	dobj	17:A1=PPT
19	regarding	regard	VBG	_	17	prep	_
20	their	their	PRP$	_	21	poss	_
21	operations	operation	NNS	_	19	pobj	_
22	from	from	IN	_	19	prep	_
23	various	various	JJ	_	26	amod	_
24	Chinese	chinese	JJ	_	26	amod	_
25	governmental	governmental	JJ	_	26	amod	_
26	agencies	agency	NNS	_	22	pobj	_
27	"	"	''	_	19	punct	_
28	,	,	,	_	33	punct	_
29	Merck	merck	NNP	_	30	nn	_
30	spokesman	spokesman	NN	_	32	nn	_
31	Steven	steven	NNP	_	32	nn	_
32	Cragle	cragle	NNP	_	33	nsubj	33:A0
33	said	say	VBD	pb=say.01	0	root	_
34	via	via	IN	_	33	prep	33:AM-MNR
35	email	email	NN	_	34	pobj	_
36	.	.	.	_	33	punct	_

1	Pfizer	pfizer	NNP	_	2	nn	_
2	Inc	inc	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	that	that	IN	_	7	complm	_
5	it	it	PRP	_	7	nsubj	7:A0=PAG;17:A0=PAG
6	regularly	regularly	RB	_	7	advmod	7:AM-MNR
7	interacted	interact	VBD	p2=JJ|pb=interact.01	3	ccomp	3:A1=PPT
8	with	with	IN	_	7	prep	7:A1=COM
9	government	government	NN	_	12	nn	_
10	and	and	CC	_	9	cc	_
11	regulatory	regulatory	JJ	_	12	amod	_
12	agencies	agency	NNS	_	8	pobj	_
13	in	in	IN	_	12	prep	_
14	China	china	NNP	_	13	pobj	_
15	"	"	''	p2=``	7	punct	_
16	to	to	TO	_	17	aux	_
17	discuss	discuss	VB	pb=discuss.01	7	advcl	7:AM-PRP
18	a	a	DT	_	19	det	_
19	variety	variety	NN	_	17	dobj	17:A1=PPT
20	of	of	IN	_	19	prep	_
21	issues	issue	NNS	_	20	pobj	_
22	,	,	,	_	21	punct	_
23	including	include	VBG	_	21	prep	_
24	patient	patient	JJ	p2=NN	25	amod	_
25	access	access	NN	_	23	pobj	_
26	,	,	,	_	25	punct	_
27	regulatory	regulatory	JJ	p2=NN	25	conj	_
28	and	and	CC	_	27	cc	_
29	compliance	compliance	NN	_	27	conj	_
30	matters	matter	NNS	_	25	conj	_
31	,	,	,	_	23	punct	_
32	and	and	CC	_	23	cc	_
33	anti-counterfeiting	anti-counterfeiting	VBG	p2=JJ|pb=anti-counterfeiting.01	23	conj	_
34	measures	measure	NNS	_	33	dobj	33:A1
35	"	"	''	_	33	punct	_
36	.	.	.	_	3	punct	_

1	Roche	roche	NNP	_	3	nn	_
2	Holding	holding	NNP	_	3	nn	_
3	AG	ag	NNP	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	it	it	PRP	_	9	nsubjpass	9:A1=PPT;11:A1
6	had	have	VBD	_	9	aux	_
7	not	not	RB	_	9	neg	9:AM-NEG;11:AM-NEG
8	been	be	VBN	_	9	auxpass	_
9	contacted	contact	VBN	pb=contact.01	4	ccomp	4:A1=PPT
10	or	or	CC	_	9	cc	_
11	investigated	investigate	VBN	pb=investigate.01	9	conj	_
12	by	by	IN	_	11	agent	11:A0
13	Chinese	chinese	JJ	_	14	amod	_
14	authorities	authority	NNS	_	12	pobj	_
15	over	over	IN	_	11	prep	11:A2=PPT
16	allegations	allegation	NNS	_	15	pobj	_
17	of	of	IN	_	16	prep	_
18	corruption	corruption	NN	_	17	pobj	_
19	,	,	,	_	4	punct	_
20	while	while	IN	_	24	mark	_
21	a	a	DT	_	23	det	_
22	Novartis	novartis	NNP	_	23	nn	_
23	spokeswoman	spokeswoman	NN	_	24	nsubj	24:A0
24	said	say	VBD	pb=say.01	4	advcl	_
25	she	she	PRP	_	26	nsubj	26:A1=PPT
26	was	be	VBD	pb=be.01	24	ccomp	24:A1=PPT
27	not	not	RB	_	26	neg	26:AM-NEG
28	aware	aware	JJ	_	26	acomp	26:A2=PRD
29	of	of	IN	_	28	prep	_
30	any	any	DT	_	31	det	_
31	contact	contact	NN	_	29	pobj	_
32	from	from	IN	_	31	prep	_
33	authorities	authority	NNS	_	32	pobj	_
34	in	in	IN	_	33	prep	_
35	China	china	NNP	_	34	pobj	_
36	around	around	IN	p2=RB	33	prep	_
37	corruption	corruption	NN	_	36	pobj	_
38	.	.	.	_	4	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=NNS	9	nsubj	9:A0=PAG
2	,	,	,	_	1	punct	_
3	Sanofi	sanofi	NNP	_	1	conj	_
4	and	and	CC	_	3	cc	_
5	Eli	eli	NNP	_	6	nn	_
6	Lilly	lilly	NNP	_	3	conj	_
7	did	do	VBD	_	9	aux	_
8	not	not	RB	_	9	neg	9:AM-NEG
9	have	have	VB	pb=have.03	0	root	_
10	any	any	DT	_	12	det	_
11	immediate	immediate	JJ	_	12	amod	_
12	comment	comment	NN	_	9	dobj	9:A1=PPT
13	.	.	.	_	9	punct	_

1	Lawyers	lawyer	NNS	_	4	nsubj	4:A0
2	and	and	CC	_	1	cc	_
3	consultants	consultant	NNS	_	1	conj	_
4	say	say	VBP	p2=VB|pb=say.01	0	root	_
5	a	a	DT	_	6	det	_
6	case	case	NN	_	8	nsubj	_
7	as	as	RB	p2=IN	8	advmod	_
8	severe	severe	JJ	_	4	ccomp	4:A1=PPT
9	as	as	IN	_	11	mark	_
10	GSK	gsk	NNP	_	11	nsubj	11:A1=PPT;15:A1=PPT
11	is	be	VBZ	pb=be.01	8	advcl	_
12	unlikely	unlikely	JJ	_	11	acomp	11:A2=PRD
13	to	to	TO	_	15	aux	_
14	be	be	VB	_	15	auxpass	_
15	repeated	repeat	VBN	pb=repeat.01	12	xcomp	_
16	anytime	anytime	RB	_	17	advmod	_
17	soon	soon	RB	_	15	advmod	15:AM-TMP
18	,	,	,	_	4	punct	_
19	but	but	CC	_	4	cc	_
20	that	that	IN	_	27	mark	_
21	the	the	DT	_	22	det	_
22	charges	charge	NNS	_	27	nsubj	30:A0=PAG;27:A1=PPT
23	against	against	IN	_	22	prep	_
24	the	the	DT	_	26	det	_
25	British	british	JJ	_	26	amod	_
26	firm	firm	NN	_	23	pobj	_
27	are	be	VBP	pb=be.01	4	conj	_
28	likely	likely	JJ	_	27	acomp	27:A2=PRD
29	to	to	TO	_	30	aux	_
30	open	open	VB	pb=open.01	28	xcomp	_
31	the	the	DT	_	32	det	_
32	floodgates	floodgate	NNS	p2=NN	30	dobj	30:A1=PPT
33	to	to	IN	_	30	prep	30:A3=GOL
34	a	a	DT	_	35	det	_
35	number	number	NN	_	33	pobj	_
36	of	of	IN	_	35	prep	_
37	smaller	small	JJR	_	39	amod	_
38	corruption	corruption	NN	_	39	nn	_
39	probes	probe	NNS	_	36	pobj	_
40	throughout	throughout	IN	_	39	prep	_
41	the	the	DT	_	42	det	_
42	sector	sector	NN	_	40	pobj	_
43	.	.	.	_	4	punct	_

1	Chinese	chinese	JJ	_	2	amod	_
2	police	police	NN	p2=NNS	3	nsubj	3:A0=PAG
3	charged	charge	VBD	p2=VBN|pb=charge.05	0	root	_
4	GSK	gsk	NNP	_	8	poss	_
5	's	's	POS	_	4	possessive	_
6	former	former	JJ	_	8	amod	_
7	China	china	NNP	_	8	nn	_
8	boss	boss	NN	_	3	dobj	3:A1=PPT
9	,	,	,	_	8	punct	_
10	Briton	briton	NNP	_	12	nn	_
11	Mark	mark	NNP	_	12	nn	_
12	Reilly	reilly	NNP	_	8	appos	_
13	,	,	,	_	8	punct	_
14	and	and	CC	_	8	cc	_
15	two	#crd#	CD	_	17	num	_
16	other	other	JJ	_	17	amod	_
17	colleagues	colleague	NNS	_	8	conj	_
18	with	with	IN	_	17	prep	_
19	corruption	corruption	NN	_	18	pobj	_
20	on	on	IN	_	3	prep	3:A2=PRD
21	Wednesday	wednesday	NNP	_	20	pobj	_
22	after	after	IN	_	25	mark	_
23	the	the	DT	_	24	det	_
24	probe	probe	NN	_	25	nsubj	25:A0=PAG
25	found	find	VBD	pb=find.01	3	advcl	3:AM-TMP
26	the	the	DT	_	27	det	_
27	firm	firm	NN	_	29	nsubj	29:A0=PAG;34:A0=PAG
28	had	have	VBD	_	29	aux	_
29	made	make	VBN	pb=make.02	25	ccomp	25:A1=PPT
30	billions	#crd#	NNS	_	29	dobj	29:A1=PRD
31	of	of	IN	_	30	prep	_
32	yuan	yuan	NN	p2=NNS	31	pobj	_
33	from	from	IN	_	29	prep	_
34	bribing	bribe	VBG	pb=bribe.01	33	pcomp	_
35	doctors	doctor	NNS	_	34	dobj	34:A1=PPT
36	and	and	CC	_	35	cc	_
37	hospitals	hospital	NNS	_	35	conj	_
38	.	.	.	_	3	punct	_

1	"	"	``	_	7	punct	_
2	Just	just	RB	_	4	advmod	_
3	this	this	DT	_	4	det	_
4	morning	morning	NN	_	7	npadvmod	7:AM-TMP
5	we	we	PRP	_	7	nsubj	7:A0=PAG
6	are	be	VBP	_	7	aux	_
7	starting	start	VBG	pb=start.01	29	ccomp	29:A1=PPT
8	with	with	IN	_	7	prep	7:A2=MNR
9	three	#crd#	CD	_	13	num	_
10	new	new	JJ	_	13	amod	_
11	compliance	compliance	NN	_	12	nn	_
12	investigation	investigation	NN	_	13	nn	_
13	cases	case	NNS	_	8	pobj	_
14	,	,	,	_	29	punct	_
15	"	"	''	p2=``	29	punct	_
16	John	john	NNP	_	17	nn	_
17	Huang	huang	NNP	_	29	nsubj	29:A0=PAG
18	,	,	,	_	17	punct	_
19	Shanghai	shanghai	NNP	_	21	hmod	_
20	-	-	HYPH	_	21	hyph	_
21	based	base	VBN	_	22	amod	_
22	partner	partner	NN	_	17	appos	_
23	at	at	IN	_	22	prep	_
24	law	law	NN	_	25	nn	_
25	firm	firm	NN	p2=JJ	27	nn	_
26	MWE	mwe	NNP	_	27	nn	_
27	China	china	NNP	_	23	pobj	_
28	,	,	,	_	29	punct	_
29	told	tell	VBD	pb=tell.01	0	root	_
30	Reuters	reuters	NNP	p2=NNS	29	dobj	29:A2=GOL
31	last	last	JJ	_	32	amod	_
32	week	week	NN	_	29	npadvmod	29:AM-TMP
33	.	.	.	_	29	punct	_

1	China	china	NNP	_	3	poss	_
2	's	's	POS	p2=VBZ	1	possessive	_
3	PSB	psb	NNP	p2=NN	8	nsubj	8:A0=PAG
4	and	and	CC	_	3	cc	_
5	SAIC	saic	NNP	_	3	conj	_
6	were	be	VBD	_	8	aux	_
7	actively	actively	RB	_	8	advmod	8:AM-MNR
8	visiting	visit	VBG	pb=visit.01	13	ccomp	13:A1=PPT
9	drug	drug	NN	_	10	nn	_
10	firms	firm	NNS	_	8	dobj	8:A1=COM
11	,	,	,	_	13	punct	_
12	he	he	PRP	_	13	nsubj	13:A0
13	said	say	VBD	pb=say.01	0	root	_
14	.	.	.	_	13	punct	_

1	"	"	``	_	5	punct	_
2	We	we	PRP	_	5	nsubjpass	7:A0=PAG;5:A2=GOL
3	're	be	VBP	_	5	aux	_
4	being	be	VBG	_	5	auxpass	_
5	asked	ask	VBD	p2=VBN|pb=ask.02	0	root	_
6	to	to	TO	_	7	aux	_
7	do	do	VB	pb=do.02	5	xcomp	5:A1=PPT
8	training	training	NN	p2=VBG	7	dobj	7:A1=PPT
9	on	on	IN	_	8	prep	_
10	how	how	WRB	_	12	advmod	12:R-AM-MNR
11	to	to	TO	_	12	aux	_
12	deal	deal	VB	pb=deal.01	9	pcomp	_
13	with	with	IN	_	12	prep	12:A1=PPT
14	dawn	dawn	NN	p2=JJ	15	nn	_
15	raids	raid	NNS	_	13	pobj	_
16	,	,	,	_	12	punct	_
17	how	how	WRB	_	19	advmod	19:R-AM-MNR
18	to	to	TO	_	19	aux	_
19	act	act	VB	pb=act.01	8	infmod	_
20	when	when	WRB	_	24	advmod	24:R-AM-TMP
21	people	people	NNS	_	24	nsubjpass	24:A1=PPT
22	are	be	VBP	_	24	aux	_
23	being	be	VBG	_	24	auxpass	_
24	arrested	arrest	VBN	pb=arrest.01	19	advcl	19:AM-TMP
25	,	,	,	_	5	punct	_
26	and	and	CC	_	19	cc	_
27	how	how	WRB	_	30	advmod	30:R-AM-MNR
28	individuals	individual	NNS	_	30	nsubj	30:A0=PAG
29	should	should	MD	_	30	aux	30:AM-MOD
30	respond	respond	VB	pb=respond.01	19	conj	_
31	to	to	IN	_	30	prep	30:A1=GOL
32	police	police	NN	p2=NNS	33	nn	_
33	investigations	investigation	NNS	_	31	pobj	_
34	.	.	.	_	5	punct	_
35	"	"	''	_	5	punct	_

1	In	in	IN	_	6	prep	6:AM-LOC
2	turn	turn	NN	_	1	pobj	_
3	,	,	,	_	6	punct	_
4	companies	company	NNS	_	6	nsubj	6:A0=PAG;8:A0=PAG
5	are	be	VBP	_	6	aux	_
6	looking	look	VBG	pb=look.04	19	ccomp	19:A1=PPT
7	to	to	TO	_	8	aux	_
8	boost	boost	VB	pb=boost.01	6	xcomp	6:A1=PPT
9	internal	internal	JJ	_	11	amod	_
10	compliance	compliance	NN	_	11	nn	_
11	systems	system	NNS	_	8	dobj	8:A1=PPT
12	and	and	CC	_	11	cc	_
13	training	training	NN	_	11	conj	_
14	,	,	,	_	13	punct	_
15	company	company	NN	_	16	nn	_
16	insiders	insider	NNS	_	13	conj	_
17	and	and	CC	_	16	cc	_
18	lawyers	lawyer	NNS	_	16	conj	_
19	said	say	VBD	pb=say.01	0	root	_
20	.	.	.	_	19	punct	_

1	"	"	``	_	34	punct	_
2	My	my	PRP$	_	3	poss	_
3	company	company	NN	_	6	poss	_
4	's	's	POS	_	3	possessive	_
5	compliance	compliance	NN	_	6	nn	_
6	systems	system	NNS	_	9	nsubj	9:A1=PPT
7	have	have	VBP	_	9	aux	_
8	always	always	RB	_	9	advmod	9:AM-TMP
9	been	be	VBN	pb=be.01	34	ccomp	34:A1=PPT
10	strict	strict	JJ	_	9	acomp	9:A2=PRD
11	,	,	,	_	9	punct	_
12	but	but	CC	_	9	cc	_
13	recently	recently	RB	_	16	advmod	16:AM-TMP
14	there	there	EX	_	16	expl	_
15	have	have	VBP	_	16	aux	_
16	been	be	VBN	pb=be.02	9	conj	_
17	more	more	JJR	p2=RBR	18	advmod	_
18	detailed	detailed	JJ	_	19	amod	_
19	regulations	regulation	NNS	_	16	attr	16:A1=PPT
20	,	,	,	_	16	punct	_
21	with	with	IN	_	16	prep	16:AM-PRD
22	more	more	JJR	p2=RBR	26	amod	_
23	all	all	RB	p2=DT	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	encompassing	encompass	VBG	_	26	amod	_
26	rules	rule	NNS	_	21	pobj	_
27	and	and	CC	_	26	cc	_
28	lots	lot	NNS	_	26	conj	_
29	of	of	IN	_	26	prep	_
30	internal	internal	JJ	_	31	amod	_
31	probes	probe	NNS	_	29	pobj	_
32	,	,	,	_	34	punct	_
33	"	"	''	_	34	punct	_
34	said	say	VBD	pb=say.01	0	root	_
35	a	a	DT	_	41	det	_
36	second	#ord#	JJ	p2=NN	41	amod	_
37	China	china	NNP	_	39	hmod	_
38	-	-	HYPH	_	39	hyph	_
39	based	base	VBN	_	41	amod	_
40	sales	sale	NNS	_	41	nn	_
41	rep	rep	NN	p2=VBP	34	nsubj	34:A0
42	at	at	IN	_	41	prep	_
43	a	a	DT	_	46	det	_
44	large	large	JJ	_	46	amod	_
45	US	us	NNP	_	46	nn	_
46	drugmaker	drugmaker	NN	_	42	pobj	_
47	.	.	.	_	34	punct	_

1	This	this	DT	_	3	nsubj	3:A1=PPT
2	has	have	VBZ	_	3	aux	_
3	been	be	VBN	pb=be.01	13	ccomp	13:A1=PPT
4	a	a	DT	_	5	det	_
5	boon	boon	NN	_	3	attr	3:A2=PRD
6	for	for	IN	_	5	prep	_
7	compliance	compliance	NN	_	8	nn	_
8	lawyers	lawyer	NNS	_	6	pobj	_
9	and	and	CC	_	8	cc	_
10	risk	risk	NN	_	11	nn	_
11	consultants	consultant	NNS	_	8	conj	_
12	,	,	,	_	13	punct	_
13	said	say	VBD	pb=say.01	0	root	_
14	Nat	nat	NNP	_	15	nn	_
15	Edmonds	edmonds	NNP	_	13	nsubj	13:A0
16	,	,	,	_	15	punct	_
17	a	a	DT	_	18	det	_
18	partner	partner	NN	_	15	appos	_
19	at	at	IN	_	18	prep	_
20	law	law	NN	_	21	nn	_
21	firm	firm	NN	_	23	nn	_
22	Paul	paul	NNP	_	23	nn	_
23	Hastings	hastings	NNP	_	19	pobj	_
24	and	and	CC	_	18	cc	_
25	a	a	DT	_	31	det	_
26	former	former	JJ	_	31	amod	_
27	Foreign	foreign	NNP	p2=JJ	28	nn	_
28	Corrupt	corrupt	NNP	_	29	nn	_
29	Practices	practice	NNPS	_	30	nn	_
30	Act	act	NNP	_	31	nn	_
31	litigator	litigator	NN	p2=NNP	18	conj	_
32	at	at	IN	_	31	prep	_
33	the	the	DT	_	36	det	_
34	U.S.	u.s.	NNP	_	36	nn	_
35	Justice	justice	NNP	_	36	nn	_
36	Department	department	NNP	_	32	pobj	_
37	.	.	.	_	13	punct	_

1	"	"	``	_	17	punct	_
2	The	the	DT	_	3	det	_
3	amount	amount	NN	_	12	nsubj	12:A1=PPT
4	of	of	IN	_	3	prep	_
5	resources	resource	NNS	_	6	nn	_
6	companies	company	NNS	_	8	nsubj	8:A0=PAG
7	are	be	VBP	_	8	aux	_
8	putting	put	VBG	pb=put.01	4	pcomp	_
9	into	into	IN	_	8	prep	8:A2=GOL
10	this	this	DT	_	9	pobj	_
11	has	have	VBZ	_	12	aux	_
12	increased	increase	VBN	pb=increase.01	17	ccomp	17:A1=PPT
13	exponentially	exponentially	RB	_	12	advmod	12:A2=EXT
14	,	,	,	_	17	punct	_
15	"	"	''	p2=``	17	punct	_
16	Edmonds	edmonds	NNP	p2=VBZ	17	nsubj	17:A0=PAG
17	told	tell	VBD	pb=tell.01	0	root	_
18	Reuters	reuters	NNP	_	17	dobj	17:A2=GOL
19	in	in	IN	_	17	prep	17:AM-LOC
20	Shanghai	shanghai	NNP	_	19	pobj	_
21	.	.	.	_	17	punct	_

1	The	the	DT	_	2	det	_
2	issue	issue	NN	_	11	nsubj	11:A1=PPT
3	for	for	IN	_	2	prep	_
4	drugmakers	drugmaker	NNS	p2=FW	3	pobj	_
5	-	-	:	p2=,	4	punct	_
6	both	both	CC	p2=DT	7	preconj	_
7	Chinese	chinese	JJ	p2=NNPS	4	amod	_
8	and	and	CC	_	7	cc	_
9	foreign	foreign	JJ	_	7	conj	_
10	-	-	:	p2=HYPH	11	punct	_
11	is	be	VBZ	pb=be.01	0	root	_
12	that	that	IN	p2=DT	19	complm	_
13	China	china	NNP	_	16	poss	_
14	's	's	POS	_	13	possessive	_
15	healthcare	healthcare	NN	_	16	nn	_
16	system	system	NN	_	19	nsubjpass	19:A1=PPT;22:A1=GOL
17	is	be	VBZ	_	19	auxpass	_
18	widely	widely	RB	_	19	advmod	19:AM-MNR
19	accepted	accept	VBN	p2=JJ|pb=accept.01	11	ccomp	11:A2=PRD
20	to	to	TO	_	22	aux	_
21	be	be	VB	_	22	auxpass	_
22	riddled	riddle	VBN	pb=riddle.01	19	xcomp	19:C-A1
23	with	with	IN	_	22	prep	22:A2=PPT
24	bribery	bribery	NN	_	23	pobj	_
25	and	and	CC	_	24	cc	_
26	corruption	corruption	NN	_	24	conj	_
27	.	.	.	_	11	punct	_

1	Graft	graft	NNP	p2=NN	4	nsubjpass	6:A0=PAG;4:A1=PPT
2	is	be	VBZ	_	4	auxpass	_
3	often	often	RB	_	4	advmod	4:AM-TMP
4	used	use	VBN	p2=JJ|pb=use.01	0	root	_
5	to	to	TO	p2=IN	6	aux	_
6	smooth	smooth	VB	pb=smooth.01	4	xcomp	4:A2=PRP
7	business	business	NN	_	8	nn	_
8	ties	tie	NNS	_	6	dobj	6:A1=PPT
9	between	between	IN	_	8	prep	_
10	sales	sale	NNS	_	11	nn	_
11	reps	rep	NNS	p2=VBZ	9	pobj	_
12	and	and	CC	_	11	cc	_
13	doctors	doctor	NNS	_	11	conj	_
14	.	.	.	_	4	punct	_

1	Without	without	IN	_	8	prep	8:AM-TMP
2	these	these	DT	_	4	det	_
3	illicit	illicit	JJ	p2=NN	4	amod	_
4	payments	payment	NNS	_	1	pobj	_
5	many	many	JJ	_	6	amod	_
6	companies	company	NNS	_	8	nsubj	8:A0=PAG;10:A0=PAG
7	would	would	MD	_	8	aux	8:AM-MOD
8	struggle	struggle	VB	pb=struggle.02	16	ccomp	16:A1=PPT
9	to	to	TO	_	10	aux	_
10	compete	compete	VB	pb=compete.01	8	xcomp	8:A1=PPT
11	,	,	,	_	10	punct	_
12	lawyers	lawyer	NNS	_	16	nsubj	16:A0
13	and	and	CC	_	12	cc	_
14	company	company	NN	_	15	nn	_
15	insiders	insider	NNS	_	12	conj	_
16	said	say	VBD	pb=say.01	0	root	_
17	.	.	.	_	16	punct	_

1	This	this	DT	_	3	nsubj	3:A0=PAG
2	would	would	MD	_	3	aux	3:AM-MOD
3	pose	pose	VB	pb=pose.02	0	root	_
4	a	a	DT	_	5	det	_
5	challenge	challenge	NN	_	3	dobj	3:A1=PPT
6	for	for	IN	_	5	prep	_
7	firms	firm	NNS	_	6	pobj	_
8	as	as	IN	_	10	mark	_
9	they	they	PRP	_	10	nsubj	10:A0=PPT
10	look	look	VBP	pb=look.01	3	advcl	3:AM-ADV
11	to	to	IN	p2=TO	10	prep	10:A1=GOL
12	hit	hit	VBN	p2=VB|pb=hit.01	15	amod	_
13	steep	steep	JJ	p2=NN	15	amod	_
14	sales	sale	NNS	_	15	nn	_
15	targets	target	NNS	p2=VBZ	11	pobj	12:A1=GOL
16	under	under	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	glare	glare	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	Chinese	chinese	JJ	_	21	amod	_
21	watchdogs	watchdog	NNS	_	19	pobj	_
22	.	.	.	_	3	punct	_

1	"	"	``	_	15	punct	_
2	The	the	DT	_	4	det	_
3	whole	whole	JJ	_	4	amod	_
4	industry	industry	NN	_	6	nsubj	8:A1=PPT
5	is	be	VBZ	_	6	aux	_
6	going	go	VBG	pb=go.04	15	ccomp	15:A1=PPT
7	to	to	TO	_	8	aux	_
8	get	get	VB	pb=get.03	6	xcomp	_
9	more	more	JJR	p2=RBR	12	advmod	_
10	and	and	CC	_	9	cc	_
11	more	more	RBR	p2=JJR	12	advmod	_
12	regulated	regulated	JJ	p2=VBN	8	acomp	8:A2=GOL
13	,	,	,	_	15	punct	_
14	"	"	''	_	15	punct	_
15	said	say	VBD	pb=say.01	0	root	_
16	a	a	DT	_	17	det	_
17	source	source	NN	_	15	nsubj	15:A0
18	with	with	IN	_	17	prep	_
19	direct	direct	JJ	_	20	amod	_
20	knowledge	knowledge	NN	_	18	pobj	_
21	of	of	IN	_	20	prep	_
22	the	the	DT	_	24	det	_
23	GSK	gsk	NNP	_	24	nn	_
24	investigation	investigation	NN	_	21	pobj	_
25	.	.	.	_	15	punct	_

1	©	©	DT	p2=JJ	2	det	_
2	Copyright	copyright	NN	p2=NNP	0	root	_
3	NDTV	ndtv	NNP	_	5	nn	_
4	Convergence	convergence	NNP	_	5	nn	_
5	Limited	limited	NNP	_	2	appos	_
6	2014	0	CD	_	5	num	_
7	.	.	.	_	2	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

